Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 1
SponsorVirginia Commonwealth University

About this trial

When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.

Eligibility criteria

Qualifiers

Age <1 year

No previous diagnosis of arrhythmia

Parent/caregiver can provide informed consent

Parent/caregiver can speak and understand simple English

Disqualifiers

Age ≥ 1 year

Patient has a pacemaker or implantable cardioverter defibrillator (ICD)

Parent/caregiver is unwilling or unable to provide informed consent

Parent/caregiver is unable to speak and understand English

Trial design

Treatments tested in this trial

  • Eko Duo electronic stethoscope
  • CORE 500 electronic stethoscope

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators